INTELLIPHARMACEUTICS INTERNATIONAL INC. (IPCIF) Financial Statements
INTELLIPHARMACEUTICS INTERNATIONAL INC. (IPCIF) files with the U.S. Securities and Exchange Commission under CIK 0001474835. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- $65.73 thousand
- Net Income
- -$2.89 million
- Total Assets
- $1.43 million
- Net Cash from Operations
- -$1.39 million
Fiscal year ended Nov 30, 2022. Latest periodic SEC filing: Feb 6, 2024. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for IPCIF in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History